
Sotera Health (SHC) Stock Forecast & Price Target
Sotera Health (SHC) Analyst Ratings
Bulls say
Sotera Health is an attractive investment with strong potential for growth due to its essential services in the healthcare industry and reaffirmed financial guidance for 2026. Despite ongoing legal issues, the company appears to have a stable financial profile and expects increased profitability in the future through investments and improved pricing. The Sterigenics business, which generates the majority of revenue, has potential for margin expansion, while the Nelson Labs business is expected to see growth opportunities with new investments and regulations.
Bears say
Sotera Health is facing significant headwinds due to ongoing litigation regarding potential health risks associated with exposure to ethylene oxide (EO) in its sterilization facilities. This has resulted in a decline in its stock price and could continue to negatively impact the company's margins and distract management from pursuing growth opportunities. Additionally, the company's high debt levels could limit its ability to expand and compete in adjacent markets, and its attractive financial profile may be at risk due to potential future litigation settlements and expenses. These factors contribute to a negative outlook on Sotera's stock.
This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.
Sotera Health (SHC) Analyst Forecast & Price Prediction
Start investing in Sotera Health (SHC)
Order type
Buy in
Order amount
Est. shares
0 shares